---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-117786"
form_type: "8-K"
ticker: "SPRB"
cik: "0001683553"
company_name: "SPRUCE BIOSCIENCES, INC."
filed_at: "2024-10-28T23:59:59+00:00"
generated_at: "2026-05-30T09:43:23.266618+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Spruce Biosciences receives Nasdaq bid-price extension to April 21, 2025; moves to Capital Market

## Summary
- Received Nasdaq extension until April 21, 2025 to meet $1.00 minimum bid price.
- Stock transfer from Nasdaq Global Select to Capital Market effective Oct 28, 2024.
- Must maintain closing bid >=$1.00 for 10 consecutive business days before deadline.
- May consider reverse stock split; failure to comply could lead to delisting.
- No immediate impact on listing; company intends to monitor bid price.

## SEC filing metadata
- accession: 0000950170-24-117786
- form_type: 8-K
- ticker: SPRB
- cik: 0001683553
- company_name: SPRUCE BIOSCIENCES, INC.
- filed_at: 2024-10-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1683553/000095017024117786/0000950170-24-117786-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1683553/000095017024117786/sprb-20241024.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-117786
- JSON: https://secwatch.observer/filing/0000950170-24-117786.json
- Plain text: https://secwatch.observer/filing/0000950170-24-117786.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.